science

Pfizer granted FDA label expansion for breast cancer drug, Ibrance

Helus Pharma prices $50M public offering at $4.85 per share

Political inaction in the battle against climate change is costly and getting costlier

NASA astronauts plan to return to the moon in 2028 wearing spacesuits made with more safety features and mobility.

Recent price run-ups don’t mean a bubble is about to burst — unless you’re looking at this sector.

Galectin Therapeutics stock surges on FDA trial agreement

“This medication was generic.”

Your 401(k) match may not be as generous as it used to be

Mara Holdings general counsel Zabi sells $99,750 in stock

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,